公开(公告)号：US11124565B2

公开(公告)日：2021-09-21

申请号：US16540388

申请日：2019-08-14

Applicant: Janssen Biotech, Inc.

Inventor： Joseph Hedrick ,  Elizabeth C. Hsia ,  Paul Imm ,  Jocelyn Leu ,  Bethany Paxson ,  Mark Rigby ,  Songmao Zheng ,  Ramineh Zoka

IPC: C07K16/24 ,  A61P3/10 ,  A61P29/00 ,  A61M5/00 ,  A61M5/315 ,  A61K39/00

Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).

公开(公告)号：US10465003B2

公开(公告)日：2019-11-05

申请号：US15421473

申请日：2017-02-01

Applicant: Janssen Biotech, Inc.

Inventor： Joseph Hedrick ,  Elizabeth C. Hsia ,  Paul Imm ,  Jocelyn Leu ,  Bethany Paxson ,  Mark Rigby ,  Songmao Zheng ,  Ramineh Zoka

IPC: C07K16/24 ,  A61P3/10 ,  A61P29/00 ,  A61M5/00 ,  A61M5/315 ,  A61K39/00

Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).

公开(公告)号：US20170247444A1

公开(公告)日：2017-08-31

申请号：US15421473

申请日：2017-02-01

Applicant: Janssen Biotech, Inc.

Inventor： Joseph Hedrick ,  Elizabeth C. Hsia ,  Paul Imm ,  Jocelyn Leu ,  Bethany Paxson ,  Mark Rigby ,  Songmao Zheng ,  Ramineh Zoka

IPC: C07K16/24

CPC classification number: C07K16/241 ,  A61K2039/505 ,  A61K2039/545 ,  A61M5/003 ,  A61M5/31533 ,  A61M5/31573 ,  A61M5/31591 ,  A61P3/10 ,  A61P29/00 ,  C07K2317/21 ,  C07K2317/565

Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).

公开(公告)号：US20190092849A1

公开(公告)日：2019-03-28

申请号：US16070385

申请日：2017-02-02

Applicant: Janssen Biotech, Inc.

Inventor： Joseph Hedrick ,  Elizabeth C. Hsia ,  Paul Imm ,  Jocelyn Leu ,  Bethany Paxson ,  Mark Rigby ,  Songmao Zheng ,  Ramineh Zoka

IPC: C07K16/24 ,  A61P29/00 ,  A61P3/10 ,  A61M5/00 ,  A61M5/315

Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).